Melanoma and Nevi

0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Melanoma, which is increasing in incidence, is the most lethal skin cancer. Risk factors for melanoma include genotypic and phenotypicc haracteristics combined with environmental exposures. Germline mutations in CDKN2A and CDK4 are thought to confer high susceptibility for melanoma. Polymorphisms in the melanocortin receptor-1 gene, which is central to melanin synthesis, confer low susceptibility for melanoma. In addition to germline alterations, somatic mutations in either BRAF or NRAS mutations have been found in a high percentage of melanomas. Nevi, which are one of the strongest risk factors for melanoma, also have BRAF mutations. Prevention, early diagnosis, and treatment remain important areas for future advancements. © 2006 Humana Press Inc.

Cite

CITATION STYLE

APA

Thomas, N. E. (2006). Melanoma and Nevi. In Principles of Molecular Medicine (pp. 1004–1010). Humana Press. https://doi.org/10.1007/978-1-59259-963-9_103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free